Localities are seeing the first payments from Virginia’s settlement with opioid distributors McKesson, AmerisourceBergen and Cardinal Healthare, which the state sued for their roles in contributing to an epidemic of prescription drug abuse and addiction through false claims about their products.

Cities and counties in Virginia have spent millions of dollars dealing with the oxycontin epidemic, but they will see only small percentages of the total settlement amount, according to figures from the state’s Opioid Abatement Authority.

The national settlement with these distributors totals $26 billion. Virginia is set to receive $15 million from this initial payment, and the Opioid Abatement Authority will receive $9.94 million.

Virginia’s 133 localities will receive a total $4,066,309 as their share of the first payment from the drug distributors. Locally, the payments break down to:

• Grayson County: 0.224% ($9,109)

• Carroll County: 0.440% ($17,892)

• City of Galax: 0.139% ($565)

“Now, Virginia communities will be able to take actionable steps to fight back against the opioid epidemic, knowing that more help is on the way,” said state Attorney General Jason Miyares.

Sen. Todd Pillion — who represents part of the Twin Counties — is chairman of the Opioid Abatement Authority. “The opioid settlement represents the largest investment in local government in Virginia history and we are excited that these funds are now becoming available for localities to implement a bold strategy to remediate and abate the opioid epidemic in the commonwealth,” he said.

However, it’s unclear what kind of “bold strategy” smaller localities such as Galax could implement with $500, for example.

These payments come after Miyares announced last week a $4.2 billion national settlement with opioid distributor Teva and a $2.37 billion national settlement with Allergan. Virginia also stands to receive payments from these settlements.